Home » Topics » Regulatory

Regulatory
RSS

Requip approved for moderate to severe primary restless legs syndrome

May 6, 2005

Oral-lyn insulin spray approved in Ecuador

May 4, 2005

FDA approval for Byetta

May 3, 2005

Cypher stent approved for MRI scans immediately following implantation

April 22, 2005

Canadian approval for Sativex

April 21, 2005

New European approval for InductOs

April 20, 2005

New indication approved for Hyzaar

April 18, 2005

Ferring launches Menopur

April 14, 2005

Approval for Femara in Canada

April 14, 2005

Japanese manufacturing approval for Lulicon

April 13, 2005

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...